Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation System

首次发布于 2011 年 10 月 25 日

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

计划入组 9 人 · 首次发布于 2014 年 10 月 31 日

KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research

计划入组 60 人 · 首次发布于 2015 年 3 月 11 日

MKCC1106-MT(Mannkind Corporation)

Cannabidiol dry powder inhalation (MannKind Corporation/Receptor Life Sciences)

Dornase alfa biosimilar (MannKind Corporation)

MannKind Corp

United States

ChampionsGate Acquisition Corporation

INSULET CORPORATION

United States

MannKind Corporation Receives FDA Approval for Afrezza Inhaled Insulin in Pediatric Diabetes Patients

MannKind Secures $500 Million Strategic Financing from Blackstone to Advance Inhaled Therapeutics Pipeline

MannKind and United Therapeutics Expand Partnership for Second Pulmonary Hypertension Inhaled Therapy